Frontiers in Endocrinology (Mar 2024)
Corrigendum: Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis
Abstract
No abstracts available.Keywords
Frontiers in Endocrinology (Mar 2024)